Natural Consulting Clinic - Esther Vrzic - Naturopath

Natural Consulting Clinic - Esther Vrzic - Naturopath FaceTime and Zoom consultations available. By appointment.

Esther’s passion is to improve your health treating you the Person and not the disease using Iridology, Diet, Lifestyle Changes, Herbal Medicine & Nutritional Supplements. Initial Consultations and Follow Up Consultations are for 1 hour duration

Esther has a Bachelor of Health Science (Naturopathy) from the University of New England Armidale, Studied Naturopathy at Australasian College of Natural Therapies and has attained an Advanced Diploma of Naturopathy, Advanced Diploma of Western Herbal Medicine, Advanced Diploma of Homeopathy and Diploma of Nutrition

15/10/2025
15/10/2025
15/10/2025

Hand osteoarthritis (HOA) is a degenerative joint disease that primarily affects the distal and proximal interphalangeal joints (DIP/PIP) and the first carpometacarpal joint at the base of the thumb, causing pain, stiffness, reduced grip/pinch strength, and characteristic bony nodules (Heberden’s and Bouchard’s nodes). Compared with knee or hip OA, HOA more often presents in mid-to-late life women, frequently involves multiple small joints symmetrically, and impairs fine motor tasks rather than weight-bearing function.

High-quality herbal trials in HOA are rare; most phytotherapy studies focus on knee OA. That’s why a recent Belgian multicentre, double-blind trial of standardised Curcuma longa (turmeric) and Boswellia serrata extracts is noteworthy: over 3 months, the combination achieved a statistically significant reduction in pain versus placebo and was generally well tolerated.

The double blind, randomised controlled trial included 162 adults with symptomatic hand OA (mean age, 63.1 years; 76.5% women) who reported hand pain on ≥ 50% of days in the prior month and ≥ 48 hours before baseline, with pain ranging from 40 to 80 mm on a 100-mm visual analogue scale (VAS) in at least one hand over the last 24 hours. The primary outcome was the mean change in finger pain on both hands during the past 24 hours on the VAS over 3 months.

At 3 months (intention-to-treat analysis), patients who received the plant extracts had a greater mean VAS pain reduction of 24.7 mm compared with 16.2 mm in those who received placebo (difference, -8.5 mm; P = 0.03); similar benefit was observed at month 1 (difference, -7.0 mm; P = 0.04). Patients receiving the plant extracts vs placebo also showed significant improvements in the patient global assessment (difference, -9.6 mm; P = 0.01) and quality of life score (P = 0.01) at month 3. There were no significant differences vs placebo for the number of painful/swollen joints, functional score, grip strength and analgesic consumption.
The number of adverse effects did not differ significantly between the two groups, and most of them were unrelated to the use of plant extracts. However, one patient taking the herbal combination developed acute hepatitis, judged as “probably related” (no further details provided).

The trial intervention was two tablets/day of a product containing Curcuma longa (turmeric) standardised dry extract: 237 mg, providing 200 mg curcumin and Boswellia serrata oleoresin: 51 mg, standardised to 65% boswellic acids and vitamin D3 (cholecalciferol): 3.6 μg (144 IU). (Note there is an error in the paper that states each tablet contained 1.4 mg of vitamin D (56,000 IU). Whoops!) Higher doses of these herbs might well achieve a better result.

This was a robust, well-designed RCT with a clinically relevant primary endpoint and a statistically significant and moderate benefit vs placebo.

For more information see: https://www.medscape.com/viewarticle/combination-plant-extracts-shows-promise-hand-osteoarthritis-2025a1000h5o?ecd=mkm_ret_250830_mscpmrk-OUS_InFocus_etid7668522&uac=48709HJ&impID=7668522

and

https://pubmed.ncbi.nlm.nih.gov/40554037/

15/10/2025

⚠️ Cancer Concerns Around Popular Weight-Loss Drugs Like Ozempic

Breakthrough medications like Ozempic, Wegovy, and Mounjaro—all GLP-1 receptor agonists—have transformed weight loss and diabetes management by lowering blood sugar and suppressing appetite. Yet as their use skyrockets, scientists are investigating possible long-term cancer risks associated with these drugs.

The strongest concern centers on thyroid cancer. Animal studies show that high doses of GLP-1 drugs can trigger thyroid tumors, and a recent large French study found a possible link between prolonged human use (beyond one year) and thyroid abnormalities. As a precaution, people with a personal or family history of thyroid cancer or genetic conditions like MEN2 are advised to avoid these treatments.

Potential ties to pancreatic cancer remain speculative. While GLP-1 drugs can occasionally cause pancreatitis—an inflammation that increases pancreatic cancer risk—no clear causal link has been confirmed. Curiously, early research suggests that tirzepatide, a newer dual-acting drug, may even shrink certain tumors in animal models, though its human implications remain unknown.

It’s also important to note that obesity itself is a major cancer risk factor. Whether any reduction in cancer rates seen among users of GLP-1 drugs results from the medication’s biology or simply from weight loss remains unclear.

For now, experts stress balance: GLP-1 drugs offer powerful metabolic benefits, but long-term vigilance is essential as science continues to unravel their full safety profile.

Follow for regular scientific updates

📄 RESEARCH PAPER

📌 Julien Bezin et al, "GLP-1 Receptor Agonists and the Risk of Thyroid Cancer", Diabetes Care (2025)

13/10/2025

🙋‍♀️If you experience PMS symptoms in the lead up to your menstruation, you’re not alone.

🔎 Studies show the PMS impacts nearly half of women world-wide – that’s nearly a quarter of the population!

👉To learn more about the benefits of natural medicine to support PMS symptoms relief, click the link https://www.metagenics.com.au/blogs/health-wellness/3-nutrients-to-help-balance-pms-moods

Study reference ;Direkvand-Moghadam A, et al. Epidemiology of premenstrual syndrome (PMS). J Clin Diagn Res. 2014 Feb.

https://www.facebook.com/share/p/19pykmj4vS/?mibextid=wwXIfr
13/10/2025

https://www.facebook.com/share/p/19pykmj4vS/?mibextid=wwXIfr

Researchers have linked prenatal exposure to the common insecticide chlorpyrifos (CPF) with lasting disruptions in brain development and motor skills. The results suggest potential risks from continued pesticide exposure during pregnancy and early childhood.

CPF (0,0-diethyl-0-3,5,6-trichloro-2- pyridyl phosphorothioate), a chlorinated organophosphate, is one of the most widely used insecticides throughout the world. Only as recently as May 2025 was CPF listed under Annex A of the Stockholm Convention on Persistent Organic Pollutants (POPs), meaning a global move toward elimination, though with exemptions for specific uses for certain countries. It has been banned in several countries, including the US (food crops and residential use ban mainly), UK, Thailand and New Zealand. In Australia it is not fully banned, but its use is being severely restricted and phased out in many cases. However, it is still widely used in India, and China, a major producer, is only gradually phasing it out.

CPF can enter the bloodstream through ingestion, skin contact or inhalation. In pregnant women, it crosses the placenta to reach the foetal blood stream, where concentrations are up to 4-fold higher than in maternal tissues, then it crosses the foetal blood-brain barrier to enter the brain.

This research is the first to show that exposure before birth can lead to long-lasting and widespread molecular, cellular and metabolic alterations in the brain, in addition to impairments in fine motor coordination. The study, conducted by scientists at Columbia University Mailman School of Public Health, Children’s Hospital Los Angeles, and the Keck School of Medicine of USC, appeared in the journal JAMA Neurology.

The analysis focused on 270 children and adolescents enrolled in the Columbia Center for Children’s Environmental Health birth cohort study, all of whom were born to Latino and African-American mothers. Chlorpyrifos levels were detected in their umbilical cord blood, and they later underwent brain imaging and behavioural evaluations between the ages of 6 and 14.

The findings revealed that higher prenatal exposure was consistently linked to more pronounced disruptions in brain structure, function, and metabolism, as well as slower motor speed and impaired motor programming. Evidence across multiple neuroimaging methods indicated that the severity of abnormalities increased directly with the level of CPF exposure, suggesting a clear dose-response effect.

Residential pesticide use (now banned) was the main source of exposure for these children. However, the ongoing use in the US still results in toxic exposure from outdoor air and dust, particularly near farming areas.

“Current widespread exposures, at levels comparable to those experienced in this sample, continue to place farm workers, pregnant women, and unborn children in harm’s way. It is vitally important that we continue to monitor the levels of exposure in potentially vulnerable populations, especially in pregnant women in agricultural communities, as their infants continue to be at risk,” said Virginia Rauh, senior author on the study.

The effects observed are not “subtle statistical blips”, they reflect consistent, measurable deficits. When you combine a β ≈ –0.27 (motor programming) with β ≈ –0.30 (fine motor speed), it shows a pattern: prenatal CPF exposure harms motor control broadly. Over years of schooling and development, these “small” average deficits may translate into significant disadvantages in learning, coordination and everyday functioning.

Note: the β (beta coefficient) is the standardised regression coefficient from statistical analysis; it indicates the direction and strength of a relationship. In psychological/neurodevelopmental testing, a 0.2 standard deviation (SD) is considered a small effect, 0.5 SD is medium and 0.8 SD large. So β ≈ –0.27 SD indicates a small-to-moderate impairment.

The authors concluded that prenatal CPF exposure was associated with altered differentiation of neuronal tissue into cortical grey and white matter, increased myelination of the internal capsule and brainwide impaired metabolism. Poor motor performance that endured into late childhood and early adolescence, likely as a result of CPF-induced oxidative stress and inflammation, was a key outcome. They suggest because other pesticides also induce oxidative stress and inflammation, minimising prenatal and early life exposure to these chemicals is likely important for optimal childhood brain development.

“The disturbances in brain tissue and metabolism that we observed with prenatal exposure to this one pesticide were remarkably widespread throughout the brain,” said first author Bradley Peterson.

Can you suggest credible herbal strategies that might help remove POPs like CPF from the body? And which of these might be safe to use in pregnancy, from the second trimester onward?

For more information see: https://scitechdaily.com/common-pesticide-linked-to-remarkably-widespread-brain-abnormalities-in-children/
and https://pubmed.ncbi.nlm.nih.gov/40824645/

12/10/2025
12/10/2025
12/10/2025
12/10/2025
12/10/2025
12/10/2025

Address

Shop 4 Parker Arcade, 474 High Street
Penrith, NSW
2750

Opening Hours

Tuesday 9am - 6:30pm
Wednesday 9am - 6:30pm
Friday 9am - 6:30pm
Saturday 8:30am - 12:30pm

Telephone

+61412841260

Website

Alerts

Be the first to know and let us send you an email when Natural Consulting Clinic - Esther Vrzic - Naturopath posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category